Summary
Genetic correlations between human traits and disorders such as schizophrenia (SZ) and bipolar disorder (BD) diagnoses are well established. Improved prediction of individual traits has been obtained by combining predictors of multiple genetically correlated traits derived from summary statistics produced by genome-wide association studies, compared with single trait predictors. We extend this idea to penalized regression on summary statistics in Multivariate Lassosum, expressing regression coefficients for the multiple traits on single nucleotide polymorphisms (SNPs) as correlated random effects, similarly to multi-trait summary statistic best linear unbiased predictors (MT-SBLUPs). We also allow the SNP contributions to genetic covariance and heritability to depend on genomic annotations. We conducted simulations with two dichotomous traits having polygenic architecture similar to SZ and BD, using genotypes from 29,330 subjects from the CARTaGENE cohort. Multivariate Lassosum produced polygenic risk scores (PRSs) more strongly correlated with the true genetic risk predictor and had better discrimination power between affected and non-affected subjects than previously published sparse multi-trait (PANPRS) and univariate (Lassosum, sparse LDpred2, and the standard clumping and thresholding) methods in most simulation settings. Application of Multivariate Lassosum to predict SZ, BD, and related psychiatric traits in the Eastern Quebec SZ and BD kindred study revealed associations with every trait stronger than those obtained with univariate sparse PRSs, particularly when heritability and genetic covariance depended on genomic annotations. Multivariate Lassosum thus appears promising to improve prediction of genetically correlated traits with summary statistics for a selected subset of SNPs.
Keywords: bipolar disorder, elastic net, genetic covariance, heritability models, LASSO, multivariate linear mixed model, risk prediction, schizophrenia
Multivariate Lassosum leverages genetic correlations among human traits to achieve better performance at predicting the risk of each trait analyzed than other multi-trait and single-trait methods selecting a limited number of SNPs (sparse solution) on simulated data and real data from a study of schizophrenia and bipolar disorder.
Introduction
Most prevalent human disorders have a polygenic component; i.e., a large number of genetic variants are involved in their etiology, each accounting for only a small percentage of the phenotypic variance. A polygenic risk score (PRS), usually defined as a weighted sum of single nucleotide polymorphism (SNP) alleles,1 can stratify subjects with various levels of genetic risk for a disorder.2 However, the accuracy of prediction of individual risk remains limited for most traits (see, e.g., Figure 4 of Zhang et al.1). One avenue to improve prediction accuracy is to take advantage of pleiotropy: the involvement of some genetic variants in multiple traits, which gives rise to well-established genetic correlations between human traits such as schizophrenia (SZ) and bipolar disorder (BD) diagnoses.3,4 Indeed, combining predictors of multiple genetically correlated traits derived from summary statistics produced by genome-wide association studies (GWASs) under a mixed model framework5 or a hierarchical Bayesian model6 achieved improved prediction of individual traits compared with single-trait predictors.
The best linear unbiased predictors (BLUPs) derived from linear mixed models and their summary statistics versions SBLUP and MT-SBLUP5 are PRSs where all SNPs contribute to the prediction. Since only a certain number of variants are involved in any disorder, the coefficients of a large proportion of SNPs are likely to represent only noise under this approach. Alternative approaches select SNPs to be included in PRSs defined from summary statistics. Hu et al.6 proposed a hierarchical Bayesian model with a mixture distribution for the effect sizes where the effect of non-causal SNPs is a point mass probability at 0. Their PleioPred package is however limited to two traits, the Markov chain Monte Carlo runs required to estimate the posterior expectation of the SNP coefficients require long computing times, and these expectations never shrink to 0. Shrinking the coefficients of some SNPs to 0, essentially removing them from the PRS, is achieved via penalized regression with a LASSO (least absolute shrinkage and selection operator) penalty extended to summary statistics.7,8 While the Lassosum package of Mak et al.7 is restricted to single traits, the PANPRS package of Chen et al.8 handles multiple traits by adding a second penalty term on the log of the sum of the absolute value of coefficients for the same SNP to favor including SNPs with large total effects. It does not however model correlation of SNP effects. Our first objective was to extend LASSO-penalized regression with summary statistics to a model of correlated effects of SNPs on multiple traits.
Zhang et al.1 noted that most PRS definitions including the BLUP and Lassosum assume that every SNP has the same contribution to the heritability of the trait, which implies an inverse relationship between the SNP minor allele frequency (MAF) and its expected effect on a quantitative trait or the risk of a disorder when genotypes are standardized. Speed et al.9 showed that this model is usually unrealistic for human traits, and models allowing heritability contributions to depend on genomic annotations and more flexible relationships with MAF fit summary statistics data better. Hu et al.6 and Zhang et al.1 adapted several PRS definitions to base the contribution of each SNP on a heritability model and showed that using a model fitting GWAS data adequately improved the predictive performance of all the PRS definitions evaluated. Our second objective was to incorporate this idea into our multi-trait PRS, which involves applying annotation-based models to genetic covariances in addition to the heritabilities of the traits. By contrast, Hu et al.6 applied annotation-based models to heritabilities only.
Our Multivariate Lassosum approach is implemented in the R package multivariateLassosum extending the Lassosum package and retaining its convenient data handling features. We evaluate its performance and compare it to the performance of approaches involving SNP selection: the multi-trait PANPRS8 (attempts to apply PleioPred with sparse model6 failed), and the single-trait Bayesian approach LDpred210 and standard clumping and thresholding (C + T) approach11 in an extensive simulation study. Application of Multivariate Lassosum to predict SZ and BD, two traits with a well-established genetic correlation,4 is illustrated in the Eastern Quebec SZ and BD kindred study.
Materials and methods
Multivariate trait model
We denote the number of phenotypes by q, the number of SNP markers by p, and the number of subjects by n. Our starting point is the linear mixed model of Maier et al.5:
(Equation 1) |
where y is a length vector of centered traits defined as and is a matrix of standardized SNP genotypes defined as
where is the standardized genotype of subject i for the SNP j defined as with the number of minor alleles (0, 1, or 2) for the individual at the SNP and the empirical MAF. The standardized genotype is the same for all traits, since the SNP genotype does not vary by trait. The vector β of length is defined as , where is the genetic effect of the SNP j for the trait k. Maier et al.5 assumed a constant variance-covariance matrix across SNPs, which implies an inverse relationship between the expected absolute effect of a copy of the minor allele and the MAF, a common assumption.1 Given the evidence from Speed et al.9 that this assumption does not hold for a vast array of common human traits, we allow marker-specific covariance matrices, such that where . We describe below how can be derived from a heritability model. ε represents a random error vector with and where is a diagonal residual matrix, is a diagonal matrix, and . In the initial derivation of the estimates from individual-level data, genotypes and traits are assumed to be measured on the same subjects. As we move later to summary statistics, genotypes and traits will be allowed to be measured in different samples of subjects of different sizes. When different traits are measured in different subjects, it is impossible to estimate residual covariances between traits. Following Maier et al.,5 we set the residual covariances to 0.
Using C. R. Henderson’s expression for the logarithm of the joint probability density function of y and β, (see for instance Jiang,12 Equation 2.36), we can derive the log likelihood of model (1):
We follow a similar methodology as Mak et al.7 to derive estimates of β using the LASSO penalty,13 further allowing the penalty to be weighted to implement adaptive LASSO.14 We therefore minimize the following objective function:
(Equation 2) |
where the summation indices, j and l, represent the SNPs, while the summation index i denotes the subjects, and represents the penalty weights.
As in Maier et al.,5 we apply the proposed model to quantitative as well as dichotomous traits, which is also generally done with single traits because estimates of the parameters of this model can be obtained from summary statistics: correlations between and y and among the genotypes of SNPs in . Chen et al.8 started from the quadratic approximation of a LASSO-penalized logistic regression objective function and formally stated a series of approximations assuming small SNP effect sizes to recover the coordinate descent algorithm for the LASSO-penalized linear model based on summary statistics. When including the density of β in the expressions resulting from Chen et al.’s8 approximations, we do not recover the coordinate descent algorithm presented in the next subsection. However, Speed and Balding15 provided empirical evidence that p values from logistic and linear models are sufficiently similar when SNP effects are small to limit the impact of using logistic regression p values from GWAS for conversion into correlations, providing support for the application of the present model to dichotomous traits.
Estimation method
Using a notation similar to Mak et al.,7 we denote by , the SNP-wise correlation between the SNPs and the trait k, and by , the linkage disequilibrium (LD) matrix, a matrix of correlations between SNPs, with being the vector for trait k and being the genotype matrix for a single trait. The vectors can be approximated from publicly available summary statistics such as estimates of β coefficients and their standard errors or p values and sign of association test statistics as in Mak et al.7 Such statistics may have been derived from linear regression for quantitative traits or logistic regression for dichotomous traits. can be obtained from publicly available genotype reference databases.
Equation 2 then becomes the following:
(Equation 3) |
However, since the genotype matrices used to estimate and r will in general be different, it is more accurate to write , where is the number of subjects in the standardized genotype matrix used to estimate LD. Furthermore, in practice, traits are measured in different subjects and in different numbers. It is therefore more accurate to consider n as a vector of the number of subjects in the sample used to compute the summary statistics for the q traits rather than a single integer. In this context, Mak et al.7 noted that we are no longer in the framework of a penalized least squares problem and established that the following further regularization of the matrix solves this issue. Replacing with for some we can then rewrite Equation 3 as follows:
where . We estimate β assuming variances and covariances are known. In practice, estimates of variances and covariances from external sources need to be provided. Although the method allows for general genetic and residual variance terms, it is convenient to set the total variance to 1 and use heritability estimates for the proportion of the total variance explained by additive genetic contributions. We then set . This only assumes in fact that the variances of all traits are equal, as multiplicative factors of the variances cancel in the solutions for the β coefficients below. Therefore, for SNP j and trait k, we find the estimate by minimizing the objective function:
(Equation 4) |
The minimization of is an elastic net problem16 with the covariance terms of the β added to the linkage disequilibrium terms of Mak et al.7 in the quadratic penalty. Following a similar scheme as in Mak et al.,7 the solution is found by iteratively updating as follows:
if ,
if ,
where
For the weights we considered i.e., constant weight, where are the estimates from the GWAS, and γ is a tuning parameter (the original adaptive LASSO of Zou,14 except that here is in general inconsistent), and , where are the estimates from Multivariate Lassosum with (the proposal by Bühlmann and Geer17).
Selection of tuning parameters
The standard approach is to select tuning parameters in a validation set independent from the training set. Summary statistics are generally available only for the full sample on which GWASs have been conducted for each trait. We adopted the approach of Zhang et al.1 to simulate pseudo summary statistics for a training and a validation sample from full-sample summary statistics, except we let the variance of the trait differ from 1. Thus, instead of estimating , the covariance matrix of , by as in Zhang et al.,1 we instead use where is the empirical variance of . Let and be the size of the training and validation sets for trait k. In our notation, the SNP-wise correlation between SNPs and the trait k in the training set is obtained as where g is a vector of drawn from the standard Gaussian distribution, and . In our application, we set , 10% of the average of n for all traits, and .
Following Mak et al.,7 we select the value of a tuning parameter λ that maximizes the correlation between the PRS and y in a validation sample. Mak et al.7 showed that this is equivalent to the value of λ maximizing the function:
(Equation 5) |
where and is a matrix of the standardized genotypes in a sample of subjects independent from the training sample in the same format as . The range of values of λ was set such that the proportion of SNPs with represented at least 5% of all SNPs for every trait k.
Mak et al.7 also proposed a pseudovalidation approach that does not require trait values or trait-genotype correlations in the validation set. It requires a shrunken estimate of the r, which can be calculated as
where is the minimum of the posterior expected loss, which for a quantitative trait, Mak et al.18 define as a quadratic loss. Generalization to a multivariate trait would require the posterior expectation of products of β coefficients for the different traits, which would involve unknown quantities. For dichotomous traits, considering a binomial log likelihood loss requires only the posterior expectation of the β coefficients and not of their products. We derived a solution for under such loss function and used it to implement pseudovalidation in our simulations, but performance was poor, so we do not present this solution.
In the analyses of real and simulated data with Lassosum and Multivariate Lassosum reported in this work, a selection procedure was applied only to the LASSO penalty λ parameter. The s regularization parameter was set to 0.5 following the observation of Mak et al.7 that such a value of s tended to achieve the best performance. In a sensitivity analysis on simulated datasets, we also tried to set s to 0.2, 0.9, or 1.
Specification of the SNP effects covariance matrices
There is evidence that the expected heritability contributed by an SNP varies as a function of SNP characteristics for a large collection of traits, and several models have been proposed to explain it based on genomic annotations.9 Recent developments in stratified LD score regression enable to estimate such models including continuous-valued annotations.19 Shi et al.20 applied one such model, the Baseline-LD-X (BLD-X) model, to the trans-ethnic genetic covariance of one trait in two ethnically distinct populations. Here we apply it to the genetic covariance between two traits in the same population. That is, we express the expectation of the product of Z scores and for two traits in the same population as
(Equation 6) |
where is the usual LD score of SNP j with respect to annotation C taking value for SNP l instead of the trans-ethnic score of Shi et al.,20 and is thus the effect of annotation C on the genetic covariance of the two traits. We add to the model of Shi et al.20 the intercept term to account for potential sample overlap, but we fit the model with unless noted otherwise. We fit the model to and from summary statistics for traits 1 and 2 to estimate the as well as the effects of the annotations on the heritabilities. The expected heritabilities and genetic covariance contributed by each SNP j are then predicted using the values of their annotations:
and we set
Simulation framework
We simulated summary statistics for two genetically correlated traits to compare the predictive performance of the different options of Multivariate Lassosum against alternative PRS construction methods involving SNP selection. The parameters that were varied in our simulations are summarized in Table 1.
Table 1.
Parameter | Reference value | Alternative value |
---|---|---|
Training, validation, and test sample sizes | 23,330; 3,000; 3,000 | 8,139; 1,000; 1,000 |
Trait heritability (trait 1, trait 2) | high (0.47, 0.45) | low (0.10, 0.09) |
Trait polygenicity (trait 1, trait 2) | high (0.49, 0.47) | low (0.12, 0.10) |
Heritability model | derived from BLD-X model | four covariance matrices |
Trait correlation with four covariance matrices | 0.59 | 0.44 |
Sample overlap for the two traits (sensitivity) | none | inducing correlation of 0.16 and 0.32 |
We used actual genotype data on 29,330 subjects from the CARTaGENE research platform (www.cartagene.qc.ca)21 genotyped with the Illumina Global Screening Array (GSA). We filtered out variants and participants using the following criteria: genotype missing rate and MAF . We also only considered the autosomes. We then imputed the small number of remaining missing genotypes using the mode. There remained 423,552 SNPs and all 29,330 individuals. The genotype data was randomly divided into three samples: the first sample of 23,330 individuals was used to generate the summary statistics. The second sample of 3,000 individuals was used as a reference panel for PRS construction and as validation set for selecting penalty parameters. The third sample of 3,000 individuals was used to evaluate the predictive performance of the PRSs from all methods compared. To evaluate the method in smaller samples, we extracted the first three genotyping batches comprising 10,139 subjects. The numbers of subjects per sample are summarized for the full cohort of 29,330 and the reduced cohort of 10,139 in Table 1.
The two genetically correlated traits in our simulation study were inspired from SZ and BD. To obtain realistic contributions of SNPs to heritabilities and genetic covariance, we fitted the BLD-X model to the most recent SZ22 and BD23 summary statistics for the 250,652 SNPs with genotypes for which such statistics as well as LD scores and MAF were available for the European (EUR) 1000 Genomes Project sample and predicted and for each SNP j. For this prediction, annotations were available for 419,492 SNPs; the other 4,060 SNPs were assigned the baseline category for dichotomous annotations and the mean value for SNPs on the same chromosome for continuous annotations.
SNP effects were simulated following the previously proposed model24,6 that some proportion of SNPs have a causal effect on a trait and the rest of the SNPs have no effect, and there is overlap between the SNPs having a causal effect on each trait. The distribution of the effect of the causal SNPs depended on the assumed heritability model: either based on the predictions from the BLD-X model annotations as described above or constant across SNPs (resulting in a mixture of four genetic covariance matrices). Then, simulation parameters were varied as follows: for heritability, we set the variance of both traits to , and for a high observed-scale SNP heritability, we set the value for trait 1 to and for trait 2 to , the estimates reported by Maier et al.5 for SZ and BD based on the summary statistics available at the time (Psychiatric Genomic Consortium [PGC], version PGC2 for SZ and PGC1 for BD). For a low heritability, we set the observed-scale SNP heritabilities of the two traits to 0.10 and 0.09. For correlation, when we simulate a mixture of four genetic-covariance-matrices, we set the genetic correlation between the two traits to , the genetic correlation between SZ and BD presented in Maier et al.,4 for a high correlation or 0.44 for a moderate correlation (same as for the BLD-X model below). For polygenicity, we then set the probability that an SNP has a causal effect on both traits 1 and 2 to 0.35 for high polygenicity or 0.08 for low polygenicity. We also set the variance explained by an SNP and solved for the probability that an SNP has a causal effect on trait 1 alone and on trait 2 alone to obtain the proportions of SNPs influencing each trait reported in Table 1. SNPs were then randomly assigned as causal for both traits, for one of the two or for neither according to probabilities reported in the simulation parameters section of the supplemental information.
We kept the same probabilities of causality and heritabilities when we made the heritabilities and genetic covariance of the two traits depend on predictions from the BLD-X model annotations, but the assignment of trait causality status was constrained by the predictions from the BLD-X model; i.e., SNPs with a predicted heritability for either trait were set as non-causal for the trait in question in all replicates (see the simulation parameters section of the supplemental information for details and Table S1 on the proportions and numbers of SNPs for each combination of trait causality statuses). We then generated the vector of genetic effects for the SNP j for traits 1 and 2 as follows:
(Equation 7) |
where and are scaling factors so that the heritability of traits 1 and 2 equal the prespecified values and . This scaling was required because only a fraction of all SNPs actually contributing to SZ and BD heritability were included in the simulations and because the specified heritabilities of traits 1 and 2 differ from the values from the BLD-X model on the most recent summary statistics of SZ and BD. We did not impose a prespecified genetic covariance and obtained a value of genetic correlation = 0.44.
For the scenario with a mixture of four genetic covariance matrices, were generated as above with the matrix element values described in the simulation parameters section of the supplemental information. We then obtained the observed correlation coefficients for each genomic region l and each trait k using
(Equation 8) |
where is the observed correlation matrix of the region from the genotype , and is the sample size assuming and were conditionally independent given their expected value. Here we point out that we did not generate the vector of genetic effects β by genomic regions like in Mak et al.7 However, we generated the observed correlation coefficients by genomic regions, as shown in Equation 8. In a sensitivity analysis, we introduced correlation between and that could result from overlap in the samples used in the GWAS (e.g., common controls). We then have , where was set to , where , , and are the intercept term estimates from cross-trait and trait-specific Linkage Disequilibrium Score Regression fit of SZ and BD summary statistics, an approach inspired by Turley et al.25 The cross-trait intercept term estimate was leading to a between-trait summary-statistic correlation . We also simulated a scenario with more substantial sample overlap by doubling the between-trait summary-statistic correlation to .
For the subjects in the test set, the two dichotomous traits were simulated under a liability threshold model with the liability where is the true standardized genetic predictor, the variance of the environmental component is set to , and the thresholds for being affected were set such that traits 1 and 2 had prevalence 1% and 2%, respectively. The area under the receiver operating curve (AUC) was computed in the test set for the two traits using the simulated traits and PRS from every method included in the comparison.
Methods compared
We compared Multivariate Lassosum with a constant genetic covariance matrix across SNPs and with genetic covariance matrices based on the predictions from BLD-X model annotations for each SNP, although in practice one would try both models and select the one performing best in the validation set. The matrices were scaled such that the total heritability and covariances equaled the estimates for SZ and BD. Hence, the constant matrices were set to
and for the variable matrices, appropriate scaling factors were applied (these differed from and above as we do not force SNP effects to 0 like we do when we simulate the true values).
The results from Multivariate Lassosum were compared with those from a previously published multi-trait method, PANPRS,8 and from single-trait methods incorporating SNP selection: the original Lassosum,7 the sparse option of LDpred2,10 and p value thresholding, the last two implemented in the bigsnpr R package. We attempted to apply PleioPred with sparse model6 to our simulated data, but a NaN value was returned for subsets of beta coefficients despite correct matching of SNP identifiers. An exchange with PleioPred authors did not resolve this issue.
All methods were applied to the same simulated training samples. Tuning parameters of all methods were selected in the validation set, except for LDpred2 for which we used the auto option to automatically estimate the proportion of causal variants and the trait heritability from summary statistics data. This was done because LDpred2 requires individual traits in the validation set contrary to evaluating (Equation 5) as we do for Lassosum-derived approaches and p value thresholding, noting that the predictive performance of the auto option of LDpred2 matched that of the validation-based options.10 The burn-in and run length of the Gibbs sampler of LDpred2 were set to their default values. The default set of heritability values was used, but the range of the proportion of causal variants was expanded from the default 0.0001–0.2 range to the 0.0001–0.5 range (0.0001, 0.0005, 0.001, 0.005, and 0.01, followed by a sequence of 25 equally spaced values from 0.05 to 0.5) to encompass our high polygenicity scenario. PRSs obtained from the resulting grid of hyperparameter values were processed as recommended by Privé et al.10 A sequence of eight p value thresholds was used for thresholding and C + T methods: 1, 0.75, 0.5, 0.25, 0.1, 0.05, 0.001, and 1e-4. For the latter method, seven correlation thresholds were tested: 0.01, 0.05, 0.1, 0.2, 0.5, 0.8, and 0.95. For PANPRS, vectors of tuning parameter values were generated by applying the initial configuration steps to all autosomal SNPs, and then the generated vectors were passed to chromosome-specific analysis runs as recommended (personal communication with Dr. T.H. Chen). The methods compared, their parameters, and other features are summarized in Table S2.
Application to schizophrenia and bipolar disorder
Genetic correlation between SZ and BD has been established through familial coaggregation studies,26 mixed model analysis on individual data,4 as well as LD score regression on summary statistics.3,5 We illustrate the gain in predictive power of Multivariate Lassosum over single-trait methods on these two traits using trait and genotype data from the SZ and BD Eastern Quebec kindred study.27,28 The best-estimate lifetime DSM-IV diagnosis was made as outlined in previous reports.29,30 Due to the presence of SZ, BD, and related diagnoses in the same sample, the risk of bias in favor of a particular diagnosis was minimized. Signed consent was obtained from all participants or from the parents for participants under 18, as reviewed by our University Ethics Committee. SNP array genotyping was performed in two waves using DNA extracted from immortalized lymphocytes or fresh blood by affinity column (Midi prep Qiagen). The same quality control criteria were applied to both waves (see genotyping quality control procedures in the supplemental information), leaving 1,120 genotyped subjects: 507 subjects genotyped at 622,184 autosomal SNPs with the Illumina Infinium Human OmniExpress array in the first wave31 and 613 subjects genotyped at 502,425 SNPs with the Illumina GSA in the second wave. Before imputation, the phasing of our familial sample genotypes was done by Shapeit2 software, which allowed us to use the family information in the phasing process via the duoHMM algorithm.32 Imputation of all common SNPs and indels was then made on the Michigan Imputation Server using the Haplotype reference consortium panel.33 The large number of SNPs led us to select the SNPs with an MAF , as was done before,34 leaving 3,639,921 SNPs.
Since LDpred2 auto option does not require a validation set, LDpred2 auto was applied to the original univariate coefficients released by the PGC in their summary statistics ( 161,405 for SZ, 413,466 for BD). For all other methods, we generated pseudo summary statistics for SZ and BD to mimic a validation set of size 28,744 and training sets of size 132,661 for SZ and 384,722 for BD by applying the approach described in materials and methods to the 6,398,847 SNPs with summary statistics for SZ22 and BD23 on the autosomal genome and with genotypes imputed in both the subjects genotyped using the OmniExpress array and using the GSA array. We used the genotypes of the EUR 1000 Genomes sample as to generate the pseudo summary statistics. After selection of the tuning parameter values, the PRS coefficients of each method were re-estimated on the original summary statistics. We adapted the application of C + T and LDpred2 with a grid of hyperparameter values (including for LDpred2 the proportion of causal SNPs: LDpred2 grid-sp) to compute the selection criterion (Equation 5) on validation set pseudo summary statistics, instead of the usual approach of measuring predictive performance on the trait in the validation set. The large number of SNPs led us to perform an initial clumping to speed up PANPRS computations as recommended (personal communication with Dr. T.H. Chen). In order to obtain a common set of SNPs for SZ and BD, we assigned to each SNP the minimum of the association p value for SZ and BD. A clumping and a window size of 250 kb using Plink 1.935 led to the selection of 365,527 SNPs.
Among the 1,120 genotyped subjects, diagnoses were distributed as follows: 205 BD, 124 SZ, 35 schizoaffective disorder (SAD), 442 non-affected adult relatives (NAARs), and 314 relatives whose diagnosis was considered unknown (e.g., parents of affected subjects who were not themselves affected). BD subjects were evaluated for the presence of symptoms of psychosis, which were detected in 93 genotyped BD subjects. PRSs were standardized to have mean 0 and variance 1 in the NAARs group separately for the two genotyping arrays. Association between diagnosis and PRSs was evaluated under a logistic model estimated by generalized estimating equation with a variance estimator robust to familial dependence.
SNP-specific contributions to heritabilities and covariances were predicted from the BLD-X heritability model fitted to pseudo summary statistics for the 3,324,089 SNPs with LD scores and MAF available for the EUR sample using the approach described above. Annotations were available for 3,611,681 SNPs; values were imputed for the other 28,240 SNPs as for the simulations above. In this model fit, after setting negative SNP predicted heritabilities to 0, some predicted covariances led to non-semi-positive definite genetic covariance matrices, and these covariances were replaced by , where is the predicted contribution of SNP j to SZ and to BD. The sum of the corrected contributions of the 3,639,921 SNPs were 0.85 for SZ, 0.17 for BD, and 0.12 for the covariance between SZ and BD (genetic correlation = 0.31). These values were used to define the constant covariance matrix for the analysis with equal contribution of all SNPs. The sample of subjects genotyped with the OmniExpress array were used as reference panel for all PRS methods.
Results
Simulation study
The version of Multivariate Lassosum with the heritability model best fitting the simulated data (e.g., BLD-X for the simulation scenarios where heritability and genetic covariance depended on genomic annotations) applied to the two simulated traits generally achieved higher predictive performance than competing methods analyzing either both traits jointly or each trait separately in terms of estimated PRS vs. true predictor correlation and AUC (Figures 1 and S2) in the reference scenario and when reducing the sample size, correlation, or heritability. In the scenario with low polygenicity, the original Lassosum performed about as well as Multivariate Lassosum for trait 1. In this instance, the original Lassosum and LDpred2 achieved better performance than the version of Multivariate Lassosum with the less adapted heritability model. Under the other scenarios where the data were generated with a mixture of four genetic covariance matrices, the original Lassosum and LDpred2 also outperformed Multivariate Lassosum with the BLD-X model. Although many of the above reported performance differences were small, Figures 2 and S2–S5 show that they were statistically significant.
The performances of Multivariate Lassosum and the other PRS methods were insensitive to the variation of most simulation parameters, except heritability. Correlation of summary statistics due to overlap of the samples for the two traits had also little impact on performance even when summary-statistic correlation was doubled compared with the estimate for SZ and BD (Figures S6 and S7). The fixed value 0.5 for the regularization parameter s led to optimal or near optimal performance of Multivariate Lassosum under the reference simulation scenario (Figure S8). Using an adaptive LASSO penalty did not improve the predictive performance over the initial analysis with a constant penalty for all coefficients. We show the results when adaptive weights were defined using the coefficient estimates from the Multivariate Lassosum analysis with constant penalty; results using the weight definition inspired by Zou14 were nearly identical (not shown). Computing times on a multi-threaded computer cluster for a Multivariate Lassosum run were a little shorter than two runs of Lassosum for the two traits, with the BLD-X model requiring slightly more time than the constant genetic covariance matrix (Table 2). LDpred2 being limited to a single node, we could only request half the number of cores as the Lassosum-derived methods, while we were restricted to a single core for PANPRS. This led to consequently larger computing times. The requested random access memory of 10 Gb per core (20 Gb for PANPRS) is an upper bound on the actual memory used.
Table 2.
Methods | Cores used | n = 29,330; p = 423,552 | n = 10,139; p = 479,158 |
---|---|---|---|
mvL | 80 | 11.86 (0.33) | 7.32 (0.42) |
mvL (BLD-X) | 80 | 13.25 (0.31) | 7.78 (0.11) |
mvL-adap | 80 | 11.94 (0.09) | 7.41 (0.43) |
mvL-adap (BLD-X) | 80 | 12.24 (0.12) | 7.47 (0.41) |
Lassosuma | 80 | 15.72 (0.04) | 7.71 (0.91) |
LDpred2a | 40 | 23.25 (0.29) | 22.01 (4.29) |
PANPRS | 1 | 2,992 (68) | 3,834 (80) |
Cumulative time of two runs, one on each of the two traits.
Analysis of schizophrenia and bipolar disorder
The selection criterion (Equation 5) evaluated on pseudo summary statistics of SZ and BD validation sets reached a higher value for Multivariate Lassosum PRSs under the BLD-X model than under a constant genetic covariance matrix. Although this implies selection of the BLD-X model, we report results from the application of both models to the test set in Figure 3 and Tables S3 and S4 to be able to compare them. Multivariate Lassosum PRSs explained a greater proportion of the variance of SZ, BD, and SAD and had better discrimination power between affected and non-affected subjects as measured by the AUC, and the odds ratios of these disorders for an increase of 1 SD in Multivariate Lassosum PRSs were larger than for competing methods in the Eastern Quebec SZ and BD kindred sample (Figure 3 and Table S3) when the PRS was defined based on GWAS of the same disorder (SZ with SZ and BD with BD) and in some cases when the PRS was defined based on other disorders (SZ and SAD with BD summary statistics and BD with SZ summary statistics). Odds ratios between quartiles of risk defined from Multivariate Lassosum PRSs tended to also be larger than for PRSs of other methods in the same instances, with more variability than the odds ratios for an increase of 1 SD (Figure S9). For SAD with SZ summary statistics, C + T performed best instead.
The BLD-X model slightly improved the proportion of explained variance, AUC, and odds ratio over the constant genetic covariance matrix for BD when predicting from SZ pseudo summary statistics and for SZ and BD when predicting from BD pseudo summary statistics, and the two models performed similarly for the other analyses where mvL performed best among the evaluated methods. The largest odds ratio, liability-scale , and AUC were achieved for SAD and the largest observed-scale for BD, both with PRSs derived from BD pseudo summary statistics. Distinguishing BD with and without psychosis did not impact substantially the variance explained and odds ratios for PRSs derived from BD pseudo summary statistics, as well as for PRSs derived from SZ pseudo summary statistics (Table S4). The BLD-X model generally led to better performance than the constant genetic covariance matrix for BD with and without psychosis, irrespective of whether SZ or BD pseudo summary statistics were used. We repeated the analysis after fitting the BLD-X model with an intercept term in Equation 6 and the results remained almost identical (not shown).
Discussion
We have combined multivariate linear mixed models and a LASSO penalty to propose Multivariate Lassosum, a new summary-statistics-based multivariate penalized regression approach to the definition of PRS for genetically correlated traits. This multivariate analysis improved the prediction of each trait compared with analyzing either two traits jointly or each trait separately using alternative methods involving the selection of SNPs (PANPRS, thresholding with and without clumping, LDpred2, and the original Lassosum) on both summary statistics simulated under a variety of scenarios and actual SZ and BD summary statistics. LDpred2 and the original Lassosum were competitive with Multivariate Lassosum only with low trait polygenicity. There are other PRS definitions involving some form of shrinkage of the SNP coefficients without forcing them to 0, but none of them consistently beat LDpred2 in a thorough evaluation on actual data for psychiatric traits,34 and we consider LDpred2 as representative of single-trait methods achieving top predictive performance.
We also adapted the S-LDXR method initially proposed to estimate the trans-ethnic genetic covariance of one trait to estimate the genetic covariance between two traits as a function of SNP annotations, and we found that using such a model (BLD-X) to predict SNP-specific contributions to the heritabilities and genetic covariance of two traits improved the predictive performance when simulated SNP effects actually depended on the included SNP annotations, even though the simulation model did not coincide with the analysis model (Figure 1). However, when the simulation model was very different from the BLD-X model, such as a mixture of four genetic covariance matrices, the predictive performance degraded, and then a constant genetic covariance matrix performed better than the BLD-X model (Figure S1). Thus, proximity of the analysis model to the true underlying model is important to maximize predictive performance, and the heritability model maximizing correlation between PRS and traits in a validation sample should be selected. When predicting SZ and BD in an actual sample of patients and non-affected relatives, the BLD-X model slightly improved predictive performance for a majority of the tested traits over the constant genetic covariance model, and otherwise the two models performed similarly. This is slightly more favorable to the BLD-X model than the results of Ni et al.,34 who reported no advantage with a similar heritability model implemented in MegaPRS1 for predicting SZ and major depressive disorder analyzed separately. Tissue-specific annotations can be added to the BLD-X model.20 Whether adding brain-specific annotations improves the prediction of SZ and BD could be investigated in future work.
We focused our evaluation of the methods on a pair of traits, although the methodology and software code are general for traits. This is essentially to limit computing time, which grows faster than linearly with the number of traits. Also, we set the total variance of each trait to 1. For quantitative traits, equal variance can be obtained by scaling the traits. For dichotomous traits, this equal variance assumption may not hold, and further investigation of the impact of different variances for the traits analyzed remains an important avenue of further research.
The covariance terms of the β added to the quadratic penalty in Equation 2 leads to BLUPs under a linear mixed model.5 In the elastic net context of Multivariate Lassosum, a different penalty strength may be optimal, which could be implemented by an additional penalty parameter to the term . Additional tuning parameters add to the computational burden but may not improve predictive performance significantly, as PANPRS exemplifies.
The improvements in prediction performance achieved by considering genetically correlated traits in the construction of PRS could be meaningful in conjunction with other factors. As with other complex traits, non-genetic factors play an important role in the etiology of SZ and BD, such as childhood trauma36,37 and socio-economic factors.38,39 Given the moderate proportions of variance of these psychiatric traits explained by PRSs, these other factors need to be considered together with PRS to further improve prediction, whether in help-seeking individuals40 or in children at familial risk.41 Genetic correlation among traits also complexifies the prediction of the specific disorder that an at-risk subject will express, as the same subject may exhibit high PRSs for multiple correlated traits. This may not be a serious impediment to implementing preventive interventions, as such interventions may be indicated to prevent several genetically correlated disorders, e.g., cognitive remediation therapy in the case of prevention of SZ and BD.
In conclusion, the availability of summary statistics for a multitude of genetically correlated traits offers an opportunity to improve risk prediction of complex disorders through PRS in conjunction with non-genetic factors. We have made available Multivariate Lassosum as a software package to implement prediction of genetically correlated traits under a penalized regression framework.
Acknowledgments
We thank Osvaldo Espin-Garcia (University Health Network, Toronto) for providing us PANPRS64, an optimized version of the SummaryLasso package. We are grateful to Yvon C. Chagnon for managing our molecular biology laboratory, to the professional research assistants Louise Bélanger, Marie-Claude Boisvert, Linda René, Lisette Gagnon, Claudie Poirier, Nicole Leclerc, Julie Lamarche, Pierrette Boutin, Lise St-Germain, Mélanie Mercier, Jordie Croteau, Alain Fournier, Valérie Jomphe, and Isabel Moreau (Center de recherche CERVO), to Claudia Moreau (Université du Québec à Chicoutimi), and to the family members who participated in the Eastern Quebec SZ and BD kindred study, which was funded by a Canada Research Chair (#950-200810) in psychiatric genetics of which Maziade is the Chair and by Canadian Institutes of Health Research grants (#MOP-74430, #MOP-114988, #PCG-155471, and #PJT-175122). This research project was funded by the New Frontiers in Research Fund, Exploration grant 2019-00752. The data management system was supported by the Canada Foundation for Innovation Leadership Opportunity Fund (grant 27592).
Declaration of interests
The authors declare no competing interests.
Footnotes
Supplemental information can be found online at https://doi.org/10.1016/j.xhgg.2023.100209.
Web resources
-
•
Multivariate Lassosum: https://github.com/abureau/multivariateLassosum
- •
-
•
Lassosum: https://github.com/tshmak/lassosum
-
•
LDpred2: https://github.com/privefl/bigsnpr
- •
-
•
1000 Genomes Project Phase 3 data: https://www.internationalgenome.org
-
•
PGC summary statistics data: https://www.med.unc.edu/pgc/results-and-downloads
- •
-
•
Shapeit2: https://mathgen.stats.ox.ac.uk/genetics_software/shapeit/shapeit.html
-
•
Michigan Imputation Server: https://imputationserver.sph.umich.edu
Supplemental information
Data and code availability
Scripts in R code for the simulation study and analysis of schizophrenia and bipolar disorder are available on Github (https://github.com/abureau/multitrait_PRS_comparison). Simulated data to reproduce certain steps of the simulation study are available as Bahda, Meriem; Ricard, Jasmin; Bureau, Alexandre (2023), “multivariateLassosum_Simulations,” Mendeley Data, v2: https://doi.org/10.17632/jxz9jwssf6.2. The data of the Eastern Quebec SZ and BD kindred study are available on request from the corresponding author. The data from the CARTaGENE project are available after approval of an access request submitted at https://www.cartagene.qc.ca/en/researchers/access-request.html. The data are not publicly available due to privacy and ethical restrictions.
References
- 1.Zhang Q., Privé F., Vilhjálmsson B., Speed D. Improved genetic prediction of complex traits from individual-level data or summary statistics. Nat. Commun. 2021;12:4192. doi: 10.1038/s41467-021-24485-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Khera A.V., Chaffin M., Aragam K.G., Haas M.E., Roselli C., Choi S.H., Natarajan P., Lander E.S., Lubitz S.A., Ellinor P.T., et al. Genome-wide polygenic scores for common diseases identify individuals with risk equivalent to monogenic mutations. Nat. Genet. 2018;50:1219–1224. doi: 10.1038/s41588-018-0183-z. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Bulik-Sullivan B., Finucane H.K., Anttila V., Gusev A., Day F.R., Loh P.-R., Psychiatric Genomics Consortium. Genetic Consortium for Anorexia Nervosa of the Wellcome Trust Case Control Consortium 3. Duncan L., et al. an atlas of genetic correlations across human diseases and traits. Nat. Genet. 2015;47:1236–1241. doi: 10.1038/ng.3406. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Maier R., Moser G., Chen G.-B., Ripke S., Cross-Disorder Working Group of the Psychiatric Genomics Consortium. Coryell W., Potash J.B., Scheftner W.A., Shi J., Weissman M.M., et al. Joint analysis of psychiatric disorders increases accuracy of risk prediction for schizophrenia, bipolar disorder, and major depressive disorder. Am. J. Hum. Genet. 2015;96:283–294. doi: 10.1016/j.ajhg.2014.12.006. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Maier R.M., Zhu Z., Lee S.H., Trzaskowski M., Ruderfer D.M., Stahl E.A., Ripke S., Wray N.R., Yang J., Visscher P.M., Robinson M.R. Improving genetic prediction by leveraging genetic correlations among human diseases and traits. Nat. Commun. 2018;9:989. doi: 10.1038/s41467-017-02769-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Hu Y., Lu Q., Liu W., Zhang Y., Li M., Zhao H. Joint modeling of genetically correlated diseases and functional annotations increases accuracy of polygenic risk prediction. PLoS Genet. 2017;13 doi: 10.1371/journal.pgen.1006836. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Mak T.S.H., Porsch R.M., Choi S.W., Zhou X., Sham P.C. Polygenic scores via penalized regression on summary statistics. Genet. Epidemiol. 2017;41:469–480. doi: 10.1002/gepi.22050. [DOI] [PubMed] [Google Scholar]
- 8.Chen T.-H., Chatterjee N., Landi M.T., Shi J. A penalized regression framework for building polygenic risk models based on summary statistics from genome-wide association studies and incorporating external information. J. Am. Stat. Assoc. 2021;116:133–143. doi: 10.1080/01621459.2020.1764849. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Speed D., Holmes J., Balding D.J. Evaluating and improving heritability models using summary statistics. Nat. Genet. 2020;52:458–462. doi: 10.1038/s41588-020-0600-y. [DOI] [PubMed] [Google Scholar]
- 10.Privé F., Arbel J., Vilhjálmsson B.J. LDpred2: better, faster, stronger. Bioinformatics. 2020;36:5424–5431. doi: 10.1093/bioinformatics/btaa1029. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.International Schizophrenia Consortium. Purcell S.M., Wray N.R., Stone J.L., Visscher P.M., O’Donovan M.C., Sullivan P.F., Sklar P. Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature. 2009;460:748–752. doi: 10.1038/nature08185. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Jiang J. Springer Series in Statistics. Springer New York; 2007. Linear and generalized linear mixed models and their applications. [Google Scholar]
- 13.Tibshirani R. Regression shrinkage and selection via the Lasso. J. Roy. Stat. Soc. B. 1996;58:267–288. [Google Scholar]
- 14.Zou H. The adaptive lasso and its oracle properties. J. Am. Stat. Assoc. 2006;101:1418–1429. [Google Scholar]
- 15.Speed D., Balding D.J. SumHer better estimates the SNP heritability of complex traits from summary statistics. Nat. Genet. 2019;51:277–284. doi: 10.1038/s41588-018-0279-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Zou H., Hastie T. Regularization and variable selection via the elastic net. J. R. Stat. Soc. Ser. B-Stat. Methodol. 2005;67:301–320. [Google Scholar]
- 17.Bühlmann P., Geer S.A.v. d. Springer Series in Statistics. Springer, Heidelberg; 2011. Statistics for high-dimensional data: methods, theory and applications. [Google Scholar]
- 18.Mak T.S.H., Kwan J.S.H., Campbell D.D., Sham P.C. Local true Discovery rate weighted polygenic scores using GWAS summary data. Behav. Genet. 2016;46:573–582. doi: 10.1007/s10519-015-9770-2. [DOI] [PubMed] [Google Scholar]
- 19.Gazal S., Finucane H.K., Furlotte N.A., Loh P.-R., Palamara P.F., Liu X., Schoech A., Bulik-Sullivan B., Neale B.M., Gusev A., Price A.L. Linkage disequilibrium-dependent architecture of human complex traits shows action of negative selection. Nat. Genet. 2017;49:1421–1427. doi: 10.1038/ng.3954. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Shi H., Gazal S., Kanai M., Koch E.M., Schoech A.P., Siewert K.M., Kim S.S., Luo Y., Amariuta T., Huang H., et al. Population-specific causal disease effect sizes in functionally important regions impacted by selection. Nat. Commun. 2021;12:1098. doi: 10.1038/s41467-021-21286-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Awadalla P., Boileau C., Payette Y., Idaghdour Y., Goulet J.-P., Knoppers B., Hamet P., Laberge C., CARTaGENE Project Cohort profile of the cartagene study: quebec’s population-based biobank for public health and personalized genomics. Int. J. Epidemiol. 2013;42:1285–1299. doi: 10.1093/ije/dys160. [DOI] [PubMed] [Google Scholar]
- 22.Trubetskoy V., Pardiñas A.F., Qi T., Panagiotaropoulou G., Awasthi S., Bigdeli T.B., Bryois J., Chen C.-Y., Dennison C.A., Hall L.S., et al. Mapping genomic loci implicates genes and synaptic biology in schizophrenia. Nature. 2022;604:502–508. doi: 10.1038/s41586-022-04434-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Mullins N., Forstner A.J., O’Connell K.S., Coombes B., Coleman J.R.I., Qiao Z., Als T.D., Bigdeli T.B., Børte S., Bryois J., et al. Genome-wide association study of more than 40,000 bipolar disorder cases provides new insights into the underlying biology. Nat. Genet. 2021;53:817–829. doi: 10.1038/s41588-021-00857-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Frei O., Holland D., Smeland O.B., Shadrin A.A., Fan C.C., Maeland S., O’Connell K.S., Wang Y., Djurovic S., Thompson W.K., et al. Bivariate causal mixture model quantifies polygenic overlap between complex traits beyond genetic correlation. Nat. Commun. 2019;10:2417. doi: 10.1038/s41467-019-10310-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Turley P., Walters R.K., Maghzian O., Okbay A., Lee J.J., Fontana M.A., Nguyen-Viet T.A., Wedow R., Zacher M., Furlotte N.A., et al. Multi-trait analysis of genome-wide association summary statistics using mtag. Nat. Genet. 2018;50:229–237. doi: 10.1038/s41588-017-0009-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Van Snellenberg J.X., de Candia T. Meta-analytic evidence for familial coaggregation of schizophrenia and bipolar disorder. Arch. Gen. Psychiatry. 2009;66:748–755. doi: 10.1001/archgenpsychiatry.2009.64. [DOI] [PubMed] [Google Scholar]
- 27.Maziade M., Roy M.-A., Chagnon Y.C., Cliche D., Fournier J.-P., Montgrain N., Dion C., Lavallée J.C., Garneau Y., Gingras N., et al. Shared and specific susceptibility loci for schizophrenia and bipolar disorder: a dense genome scan in eastern quebec families. Mol. Psychiatry. 2005;10:486–499. doi: 10.1038/sj.mp.4001594. [DOI] [PubMed] [Google Scholar]
- 28.Chagnon Y.C., Maziade M., Paccalet T., Croteau J., Fournier A., Roy M.-A., Bureau A. A multimodal attempt to follow-up linkage regions using RNA expression, SNPs and CpG methylation in schizophrenia and bipolar disorder kindreds. Eur. J. Hum. Genet. 2020;28:499–507. doi: 10.1038/s41431-019-0526-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Maziade M., Roy M.A., Fournier J.P., Cliche D., Mérette C., Caron C., Garneau Y., Montgrain N., Shriqui C., Dion C. Reliability of best-estimate diagnosis in genetic linkage studies of major psychoses: results from the quebec pedigree studies. Am. J. Psychiatr. 1992;149:1674–1686. doi: 10.1176/ajp.149.12.1674. [DOI] [PubMed] [Google Scholar]
- 30.Roy M.A., Lanctôt G., Mérette C., Cliche D., Fournier J.P., Boutin P., Rodrigue C., Charron L., Turgeon M., Hamel M., et al. Clinical and methodological factors related to reliability of the best-estimate diagnostic procedure. Am. J. Psychiatr. 1997;154:1726–1733. doi: 10.1176/ajp.154.12.1726. [DOI] [PubMed] [Google Scholar]
- 31.Boies S., Mérette C., Paccalet T., Maziade M., Bureau A. Polygenic risk scores distinguish patients from non-affected adult relatives and from normal controls in schizophrenia and bipolar disorder multi-affected kindreds. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2018;177:329–336. doi: 10.1002/ajmg.b.32614. [DOI] [PubMed] [Google Scholar]
- 32.O’Connell J., Gurdasani D., Delaneau O., Pirastu N., Ulivi S., Cocca M., Traglia M., Huang J., Huffman J.E., Rudan I., et al. A general approach for haplotype phasing across the full spectrum of relatedness. PLoS Genet. 2014;10 doi: 10.1371/journal.pgen.1004234. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.McCarthy S., Das S., Kretzschmar W., Delaneau O., Wood A.R., Teumer A., Kang H.M., Fuchsberger C., Danecek P., Sharp K., et al. A reference panel of 64,976 haplotypes for genotype imputation. Nat. Genet. 2016;48:1279–1283. doi: 10.1038/ng.3643. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Ni G., Zeng J., Revez J.A., Wang Y., Zheng Z., Ge T., Restuadi R., Kiewa J., Nyholt D.R., Coleman J.R.I., et al. A comparison of ten polygenic score methods for psychiatric disorders applied across multiple cohorts. Biol. Psychiatr. 2021;90:611–620. doi: 10.1016/j.biopsych.2021.04.018. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Chang C.C., Chow C.C., Tellier L.C., Vattikuti S., Purcell S.M., Lee J.J. Second-generation plink: rising to the challenge of larger and richer datasets. GigaScience. 2015;4:7. doi: 10.1186/s13742-015-0047-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Berthelot N., Garon-Bissonnette J., Jomphe V., Doucet-Beaupré H., Bureau A., Maziade M. Childhood trauma may increase risk of psychosis and mood disorder in genetically high-risk children and Adolescents by enhancing the Accumulation of risk indicators. Schizophrenia Bulletin Open 2022;3,sgac017. [DOI] [PMC free article] [PubMed]
- 37.Kelleher I., Keeley H., Corcoran P., Ramsay H., Wasserman C., Carli V., Sarchiapone M., Hoven C., Wasserman D., Cannon M. Childhood trauma and psychosis in a prospective cohort study: cause, effect, and directionality. Am. J. Psychiatr. 2013;170:734–741. doi: 10.1176/appi.ajp.2012.12091169. [DOI] [PubMed] [Google Scholar]
- 38.Sareen J., Afifi T.O., McMillan K.A., Asmundson G.J.G. Relationship between household income and mental disorders: findings from a population-based longitudinal study. Arch. Gen. Psychiatry. 2011;68:419–427. doi: 10.1001/archgenpsychiatry.2011.15. [DOI] [PubMed] [Google Scholar]
- 39.Silva M., Loureiro A., Cardoso G. Social determinants of mental health: a review of the evidence. Eur. J. Psychiatr. 2016;30:259–292. [Google Scholar]
- 40.Murray G.K., Lin T., Austin J., McGrath J.J., Hickie I.B., Wray N.R. Could polygenic risk scores Be useful in psychiatry?: a review. JAMA Psychiatr. 2021;78:210–219. doi: 10.1001/jamapsychiatry.2020.3042. [DOI] [PubMed] [Google Scholar]
- 41.Maziade M. At risk for serious mental illness — screening children of patients with mood disorders or schizophrenia. N. Engl. J. Med. 2017;376:910–912. doi: 10.1056/NEJMp1612520. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Data Availability Statement
Scripts in R code for the simulation study and analysis of schizophrenia and bipolar disorder are available on Github (https://github.com/abureau/multitrait_PRS_comparison). Simulated data to reproduce certain steps of the simulation study are available as Bahda, Meriem; Ricard, Jasmin; Bureau, Alexandre (2023), “multivariateLassosum_Simulations,” Mendeley Data, v2: https://doi.org/10.17632/jxz9jwssf6.2. The data of the Eastern Quebec SZ and BD kindred study are available on request from the corresponding author. The data from the CARTaGENE project are available after approval of an access request submitted at https://www.cartagene.qc.ca/en/researchers/access-request.html. The data are not publicly available due to privacy and ethical restrictions.